nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.
mobic 15 mg tablets
boehringer ingelheim international gmbh - meloxicam - tablet - 15 milligram(s) - oxicams; meloxicam
mobic
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 15 mg - antiinflammatory and antirheumatic products
mobec 15mg tabletten
mobec 7.5mg tabletten
mobic 7.5 mg tablets
boehringer ingelheim international gmbh - meloxicam - tablet - 7.5 milligram(s) - oxicams; meloxicam
mobic 7.5mg tablets
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 7.5 mg - antiinflammatory and antirheumatic products
elocom cream
organon canada inc. - mometasone furoate - cream - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents
elocom lotion
organon canada inc. - mometasone furoate - lotion - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents
elocom ointment
organon canada inc. - mometasone furoate - ointment - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents